Remission ‐ not measured · treatment‐resistant depression in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life ‐ not measured · treatment‐resistant depression in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Endpoint score (HDRS or MADRS) · somatoform disorders in adults
1 finding from 1 review
Dizziness or hypotension · dialysis patients with depression
1 finding from 1 review
Nausea · dialysis patients with depression
1 finding from 1 review
Sexual dysfunction ‐ not reported · dialysis patients with depression
1 finding from 1 review
All‐cause mortality · dialysis patients with depression
1 finding from 1 review
Adverse events (disease‐related: all physical symptoms); · chronic obstructive pulmonary disease (COPD) with depression
1 finding from 1 review
Change in quality of life · chronic obstructive pulmonary disease (COPD) with depression
1 finding from 1 review
Change in dyspnoea score · chronic obstructive pulmonary disease (COPD) with depression
1 finding from 1 review
Lung function: FEV1 mL (change from baseline) · chronic obstructive pulmonary disease (COPD) with depression
1 finding from 1 review
Change in exercise tolerance · chronic obstructive pulmonary disease (COPD) with depression
1 finding from 1 review
Change in hospital utilisation ‐ not measured · chronic obstructive pulmonary disease (COPD) with depression
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of responders · patients with depression and dementia
Antidepressant treatment showed no clear difference in number of responders (ITT) at 6 to 12 weeks compared with placebo (low certainty).
1 finding from 1 review
Remission · patients with depression and dementia
Antidepressant treatment probably leads to higher number of patients with remission (ITT) at 6 to 12 weeks compared with placebo (moderate certainty).
1 finding from 1 review
Cognitive function · patients with depression and dementia
1 finding from 1 review
Activities of daily living · patients with depression and dementia
1 finding from 1 review
Dropout · patients with depression and dementia
Antidepressant treatment probably leads to higher number of dropouts at 6 to 13 weeks compared with placebo (moderate certainty).
1 finding from 1 review
Risk for at least one adverse event per patient · patients with depression and dementia
Antidepressant treatment probably leads to higher number of patients experiencing at least one adverse event compared with placebo (moderate certainty).
1 finding from 1 review
Recurrence · older people in remission from depression
Antidepressant medication may leads to lower recurrence at 12 months compared with placebo at 12 months' follow‐up (low certainty).
1 finding from 1 review